Overview
- 20 inspections across 18 sites are on record.
- 75 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2013-09-10.
At a glance
Inspections
20
Sites
18
Observations
75
Career since
Jul 2008
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Catalent CTS, LLC | 10 Sep 2013 | Human Drugs | |
| Hospira, Inc. | 24 Oct 2012 | On file | |
| MPP PHARMA LLC | 5 Nov 2010 | On file | |
| Nesher Pharmaceuticals (USA) LLC | 20 Aug 2010 | ||
| Nesher Pharmaceuticals (USA) LLC | 20 Aug 2010 |
Sites inspected
Catalent CTS, LLCKansas City, United States1 insp.
Hospira, Inc.Mcpherson, United States1 insp.
MPP PHARMA LLCKansas City, United States1 insp.
Nesher Pharmaceuticals (USA) LLCEarth City, United States1 insp.
Nesher Pharmaceuticals (USA) LLCBridgeton, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Sherry G Bous4 shared
Eric M Mueller4 shared
Thuy T Nguyen4 shared
Bill Tackett3 shared
Michele L Obert3 shared
Tara L Breckenridge2 shared
Rochelle B Young2 shared
Patrick L Wisor2 shared
Warren J Lopicka2 shared
Shirley J Berryman1 shared
Full investigator report
Get the verbatim findings behind Matthew R Sleeter's 75 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site